MYCIO Wealth Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

MYCIO Wealth Partners’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,000	Closed	-$112K	–	884
2015 Q4	$112K	Hold	1,000	–	–	0.02%	204
2015 Q3	$96K	Hold	1,000	–	–	0.02%	211
2015 Q2	$102K	Hold	1,000	–	–	0.02%	214
2015 Q1	$62K	Buy	1,000 +300	+43%	+$16.7K	0.01%	262
2014 Q4	$31K	Buy	+700	New	+$32.1K	0.01%	335
2014 Q3	–	Sell	-700	Closed	-$31K	–	647
2014 Q2	$31K	Hold	700	–	–	0.01%	327
2014 Q1	$34K	Buy	+700	New	+$36K	0.01%	303

Other funds holding RARE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MYCIO Wealth Partners's RARE Position: Q1 2016 in Review

MYCIO Wealth Partners sold out of Ultragenyx Pharmaceutical (RARE) in Q1 2016, closing a stake of 1,000 shares — an estimated $112K sold.

MYCIO Wealth Partners first reported a position in RARE in Q1 2014 and held it in 7 quarters. The position peaked at $112K in Q4 2015. 161 funds tracked by Wall St. Rank hold RARE as of Q1 2016.

MYCIO Wealth Partners reported no remaining Ultragenyx Pharmaceutical position as of Q1 2016 after selling out during the quarter.
MYCIO Wealth Partners sold 1,000 Ultragenyx Pharmaceutical shares in Q1 2016, an estimated $112K.
MYCIO Wealth Partners first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and held it in 7 quarters.
MYCIO Wealth Partners's Ultragenyx Pharmaceutical position peaked at $112K in Q4 2015.
161 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2016.

Based on MYCIO Wealth Partners's 13F filing for Q1 2016, filed 11 May 2016.